Moderna completes FDA filing for bivalent COVID-19 booster vaccine, MR
Original SARS-CoV-2 monovalent and Omicron BA.4/BA.5 bivalent COVID-19 mRNA vaccines: phase 2/3 trial interim results | Nature Medicine
FDA Authorizes Moderna, Pfizer-BioNTech Bivalent COVID-19 Booster Doses - Pharmacy Practice News
Moderna says updated booster generated 'significantly higher' neutralizing antibodies against BA.4/BA.5 subvariants - ABC7 Chicago
Moderna Says Omicron Tailored COVID-19 Shots Shows Better Immune Response Than Original Vaccine
Moderna Is Developing Two Different Omicron-Targeting Booster Shots - WSJ
Moderna: New booster protects better against variants - The Jerusalem Post
Moderna on X: "In a Phase 2/3 trial in over 500 adults, mRNA-1273.222, induced significantly higher neutralizing antibody titers against BA.4/BA.5 compared to a booster dose of mRNA-1273. Read more: https://t.co/CPnxL03nZW https://t.co/ODihw6qtsQ" /
Moderna's Omicron-targeting vaccines meet endpoint in Phase II/III trial
Moderna on X: "We have submitted a request for emergency use authorization (EUA) for our Omicron-targeting bivalent #COVID19 #vaccine, mRNA-1273.222, in children and adolescents 12 to 17 years of age to the
Moderna on X: "A Phase 2/3 trial for mRNA-1273.222 is currently underway. We have rapidly scaled manufacturing of mRNA-1273.222 to be ready, if authorized, to deliver doses in September. https://t.co/AQG4hfwNe6" / X
EMA CHMP recommends Moderna's Covid-19 booster for children
Moderna's Omicron shots shows better immune response than original COVID vaccine | Reuters
Moderna says updated booster generated 'significantly higher' neutralizing antibodies against BA.4/BA.5 subvariants | CNN
Moderna COVID19 Bivalent vaccine (Original and Omicron BA.4/BA.5)
Moderna says its Omicron shots provide better protection than original COVID-19 jab - National | Globalnews.ca
Moderna xin cấp phép vaccine ngừa Omicron cho thanh thiếu niên, trẻ nhỏ tại Mỹ | VTV.VN
Moderna seeks FDA nod for Omicron-targeted COVID shot for adolescents, younger kids, ET HealthWorld
Moderna's BA.4/BA.5 Targeting Bivalent Booster, mRNA-1273.222, Meets Primary Endpoint of Superiority Against Omicron Variants Compared to Booster Dose of mRNA-1273 in Phase 2/3 Clinical Trial
Moderna Submits Omicron-targeting Bivalent Booster Vaccine | RT
U.S. government places $1.74B order for Moderna's new Covid-19 vaccine boosters - MedCity News
Omicron-tailored shots show better response than original COVID vaccine: Moderna | Mint
Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice | Nature Medicine
Moderna is padding the case for its bivalent COVID-19 booster
